-
1
المؤلفون: van Santen, Daniela K, Sacks-Davis, Rachel, Stewart, Ashleigh, Boyd, Anders, Young, Jim, van der Valk, Marc, Smit, Colette, Rauch, Andri, Braun, Dominique L, Jarrin, Inmaculada, Berenguer, Juan, Lazarus, Jeffrey V, Lacombe, Karine, Requena, Maria-Bernarda, Wittkop, Linda, Leleux, Olivier, Salmon, Dominique, Bonnet, Fabrice, Matthews, Gail, Doyle, Joseph S, Spelman, Tim, Klein, Marina B, Prins, Maria, Asselin, Jason, Stoové, Mark A, Hellard, Margaret, InCHEHC study group
المساهمون: Disease Elimination Program, Burnet Institute, Melbourne, Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada, Stichting HIV Monitoring [Amsterdam], Universiteit van Amsterdam (UvA), Stichting HIV Monitoring, Universität Bern [Bern] (UNIBE), Universitätsspital Zürich (USZ), Instituto de Salud Carlos III [Madrid] (ISC), Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), University of Barcelona, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Univ. Bordeaux, INSERM, Institut Bergonié BPH U1219, CIC-EC 1401, F-33000, Bordeaux, France pINRIA SISTM Team, Talence, France, Team MORPH3EUS (INSERM U1219 - UB - ISPED), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Global Health in the Global South (GHiGS), Institut de Recherche pour le Développement (IRD)- Bordeaux population health (BPH), The Kirby Institute for Infection and Immunity in Society (UNSW), University of New South Wales [Sydney] (UNSW), St. Vincent's Hospital, Sydney, Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia, McGill University = Université McGill [Montréal, Canada], Public Health Service of Amsterdam, Amsterdam UMC - Amsterdam University Medical Center, Disease Elimination Program, Burnet Institute, Melbourne, Australia, Australian Government National Health and Medical Research Council (Grantnumber GNT1132902), Graduate School, Infectious diseases, APH - Global Health, AII - Inflammatory diseases, AII - Infectious diseases, National Health and Medical Research Council (Australia)
المصدر: EClinicalMedicine
EClinicalMedicine, 2023, 56, pp.101810. ⟨10.1016/j.eclinm.2022.101810⟩
van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810 <http://dx.doi.org/10.1016/j.eclinm.2022.101810>
EClinicalMedicine, 56:101810. Lancet Publishing Groupمصطلحات موضوعية: HIV Hepatitis C virus Elimination Direct-acting antivirals Trends Incidence, Hepatitis C virus, Elimination, Incidence, HIV, 610 Medicine & health, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, General Medicine, Trends, Direct-acting antivirals
وصف الملف: application/pdf
Full Text via ClinicalKey